IPMN: A Patient Guide to “Intraductal Papillary Mucinous Neoplasm”
An IPMN is a growth in the lining of the pancreatic ducts, and the most common type of pancreatic cyst. It is not cancer. While IPMN can be a precursor to cancer: only a very small minority of IPMN cysts grow or change over many years. In most people these cysts remain small, cause no symptoms, and can just be monitored over time.
What the name means
- Intraductal — It grows inside the duct system of the pancreas
- Papillary — The lining forms tiny finger-like folds
- Mucinous — The cells produce a thick mucus.
- Neoplasm — A growth. The word is alarming to most people, understandably. It means cells multiplying where they otherwise would not, and nothing beyond that.
The mucus backs up and widens the duct. That widened, fluid-filled duct is what the radiologist described as a cyst.
Two types, and why the difference matters
The pancreas drains through a single main duct that runs its whole length, with many smaller side ducts/branches feeding into it. Where the IPMN sits — on a side branch or in the main duct itself — determines how it is managed.
Branch-duct IPMN. It sits on a side branch and does not involve the main duct. This is the common type and the lower-risk type. Most are small and remain small for the rest of a person's life. Of people followed with side-branch IPMN, roughly 3 in 100 develop a pancreatic cancer over ten years. Most of that risk lies in the cysts that grow or change along the way, which is what the scans are monitoring for.
Main-duct IPMN. A cystic change involves the main duct itself, widening the duct along its length. Much less common, and managed differently, as the risk of eventual malignancy is higher. While surveillance can sometimes be considered, we will often involve our surgical colleagues to determine if and when surgery may be required to remove the high-risk area.
Mixed-type IPMN. A combination of ‘branch duct’ and ‘main duct’ IPMN. Often grouped with main-duct disease, but when there are no high-risk findings it may behave more like the branch-duct type, so management and surveillance is quite nuanced and involves careful monitoring with a multidisciplinary team.
The reason for monitoring
An IPMN offers something most cancers do not: a visible precursor, years ahead of time. Sun-related skin moles are perhaps the closest comparison. For both pancreatic cysts and skin moles, the large majority never become anything, but they are typically monitored, because in the few that do grow or change, early detection changes the outcome entirely.
There is a second reason for monitoring. Occasionally a cancer appears in a different part of the pancreas altogether, not in the cyst. The whole gland is therefore imaged, and new symptoms are taken seriously even when the cyst itself appears unchanged.
What monitoring involves
We usually monitor pancreatic cysts with a specialized type of MRI scan called an ‘MRCP’. This type of scan shows the ducts clearly and without radiation exposure. Intervals range from six months to two years depending on the size and character of the cyst.
Three things are compared across scans: the size of the cyst and how quickly it is changing, the caliber of the main duct, and whether any solid nodule has appeared inside the cyst.
Endoscopic ultrasound
Not everyone needs this test. It is typically used when the MRI shows something requiring a closer look, or when the type of cyst is uncertain and knowing would change the plan.
A thin flexible scope with an ultrasound probe at its tip is passed through the mouth into the stomach and duodenum, under sedation, so the pancreas can be imaged from millimeters away. That proximity gives us a more detailed view than MRI of small nodules and the cyst wall. If needed, a fine needle can be passed through the scope to sample fluid from the cyst for laboratory analysis.
Findings that would change the plan
Meaningful growth of the cyst
Widening of the main duct
A solid nodule appearing inside the cyst
A thickened cyst wall
Yellowing of the eyes or skin
An episode of pancreatitis
New diabetes, or diabetes that suddenly becomes difficult to control
Any of these prompts closer assessment, usually endoscopic ultrasound, rather than an immediate operation. Several appearing together carries more weight than one alone.
Surgery
Removing part of the pancreas is a significant operation with a substantial recovery, which is why it is not done for cysts that do not require it. It is also, in experienced hands, definitive: an IPMN removed before it turns invasive is cured. Any such discussion will be about your risk, your health, and your preferences, in that order. If part of the gland is removed, scans usually continue afterward, since the remainder of the pancreas can form new IPMNs.
Living with an IPMN
Most people with a branch-duct IPMN will have it for the rest of their lives without it ever causing a problem.
A common question is whether diet or other lifestyle changes will alter how the cyst behaves. For the most part, they will not. There is no diet, supplement, or food to avoid that has been shown to change what an IPMN does, and no reason to make restrictive changes on its own account. The two exceptions are smoking and, to a lesser degree, body weight: both have been linked to a somewhat higher chance of a cyst changing over time. Stopping smoking is worth doing, and keeping to a healthy weight is sensible for the usual reasons. Beyond that, nothing about daily life needs to change.
Mention any family history of pancreatic cancer, since that can change the plan. Between visits, notify us if you experience jaundice, unintended weight loss, new diabetes, or severe upper abdominal pain radiating through to the back.
Further information
The National Pancreas Foundation maintains plain-language information on pancreatic cysts and IPMN: pancreasfoundation.org